NewAmsterdam Pharma N.V. (NAMS)
NASDAQ: NAMS
· Real-Time Price · USD
19.75
-0.46 (-2.28%)
At close: Jun 16, 2025, 3:59 PM
20.58
4.20%
After-hours: Jun 16, 2025, 06:24 PM EDT
-2.28% (1D)
| Bid | 19 |
| Market Cap | 2.22B |
| Revenue (ttm) | 47.14M |
| Net Income (ttm) | -187.36M |
| EPS (ttm) | -1.84 |
| PE Ratio (ttm) | -10.73 |
| Forward PE | -10.6 |
| Analyst | Buy |
| Ask | 22 |
| Volume | 1,531,357 |
| Avg. Volume (20D) | 898,246 |
| Open | 19.97 |
| Previous Close | 20.21 |
| Day's Range | 18.60 - 19.97 |
| 52-Week Range | 14.06 - 27.29 |
| Beta | -0.03 |
About NAMS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NAMS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NAMS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+0.1%
NAMS stock has given up its prior gain. NewAmsterd...
Unlock content with
Pro Subscription
1 week ago
+0.1%
NewAmsterdam Pharma shares are trading higher after the company announced topline data from prespecified Alzheimer's Disease biomarker analyses in the Phase 3 BROADWAY clinical trial
